
Dr. Shroyer and colleagues discovered that K17 promotes cancer and plays a crucial role in degrading a key tumor suppressor protein. Details of this research are featured in a recent issue of Cancer Research and in this press release. They also found that K17 cervical cancer patients have a decreased chance of long-term survival when compared to patients who express little to no K17 in tumor tissue. This led the team on a path to identify K17 as a specific biomarker of cervical cancer.
Add comment